Business Description
SomaLogic Inc
NAICS : 923120
SIC : 8731
ISIN : US83444K1051
Share Class Description:
SLGC: Class ADescription
SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 164.25 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.99 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y Total Revenue Growth Rate | 5.35 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 79.01 | |||||
| 9-Day RSI | 70.85 | |||||
| 14-Day RSI | 65.45 | |||||
| 6-1 Month Momentum % | -32.88 | |||||
| 12-1 Month Momentum % | -25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.79 | |||||
| Quick Ratio | 17.29 | |||||
| Cash Ratio | 16.34 | |||||
| Days Inventory | 116.05 | |||||
| Days Sales Outstanding | 98.37 | |||||
| Days Payable | 127.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.15 | |||||
| Operating Margin % | -186.64 | |||||
| Net Margin % | -159.54 | |||||
| FCF Margin % | -149.15 | |||||
| ROE % | -24.03 | |||||
| ROA % | -21.02 | |||||
| ROIC % | -164.81 | |||||
| ROC (Joel Greenblatt) % | -308.96 | |||||
| ROCE % | -14.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.98 | |||||
| PB Ratio | 1.03 | |||||
| Price-to-Tangible-Book | 1.09 | |||||
| EV-to-EBIT | -0.72 | |||||
| EV-to-Forward-EBIT | -0.52 | |||||
| EV-to-EBITDA | -0.79 | |||||
| EV-to-Revenue | 0.76 | |||||
| EV-to-Forward-Revenue | 0.64 | |||||
| EV-to-FCF | -0.34 | |||||
| Price-to-Net-Current-Asset-Value | 1.2 | |||||
| Price-to-Net-Cash | 1.33 | |||||
| Earnings Yield (Greenblatt) % | -138.89 | |||||
| FCF Yield % | -23.92 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLGC
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SomaLogic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 81.724 | ||
| EPS (TTM) ($) | -0.69 | ||
| Beta | 0 | ||
| Volatility % | 62.85 | ||
| 14-Day RSI | 65.45 | ||
| 14-Day ATR ($) | 0.167436 | ||
| 20-Day SMA ($) | 2.31775 | ||
| 12-1 Month Momentum % | -25 | ||
| 52-Week Range ($) | 1.73 - 3.79 | ||
| Shares Outstanding (Mil) | 188.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SomaLogic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SomaLogic Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
SomaLogic Inc Frequently Asked Questions
What is SomaLogic Inc(SLGC)'s stock price today?
The current price of SLGC is $2.71. The 52 week high of SLGC is $3.79 and 52 week low is $1.73.
When is next earnings date of SomaLogic Inc(SLGC)?
The next earnings date of SomaLogic Inc(SLGC) is 2024-03-28 Est..
Does SomaLogic Inc(SLGC) pay dividends? If so, how much?
SomaLogic Inc(SLGC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers